Table 2.
Batokine | Functions or Effects | Year | Ref. |
---|---|---|---|
NGF | Sympathetic innervation | 1994 | [23] |
IL-6 | Increased thermogenesis, improved insulin sensitivity | 1997 | [24] |
VEGFA | Increased vascularization of BAT | 1999 | [25] |
BMP8B | Increased thermogenesis, increased sympathetic activation of BAT | 2012 | [26] |
FGF21 | Increased thermogenesis, improved insulin sensitivity, WAT “browning,” cardioprotective | 2012 | [27–29] |
L-PGDS | Increased thermogenesis | 2012 | [30] |
IGF-1 | Insulin mimicking effects, regulates cell growth and development | 2012 | [31] |
IGFBP-2 | Increased bone formation | 2013 | [32] |
Metrnl | Increased IL-4 expression, macrophage activation | 2014 | [33] |
NRG4 | Decreased hepatic lipogenic signaling, increased energy expenditure | 2014 | [34] |
sLR11 | Decreased thermogenesis | 2015 | [35] |
Endothelin-1 | Increased thermogenesis | 2016 | [36] |
Slit2-C | Improved glucose homeostasis, increased energy expenditure | 2016 | [37] |
PM20D1 | Improved glucose homeostasis, in-creased energy expenditure | 2016 | [38] |
NGF nerve growth factor, VEGFA vascular endothelial growth factor A, BMP8B Bone morphogenic protein 8b, FGF21 fibroblast growth factor 21, L-PGDS Lipocalin-type prostaglandin D synthase, IGF-1 insulin-like growth factor 1, IGFBP-2 insulin-like growth factor binding protein 2, Metrnl meteorin-like, NRG4 neuregulin 4, sLR11 soluble form of the low-density lipoprotein receptor relative, Slit2-C slit homolog 2 protein, C-fragment, PM20D1 peptidase M20 domain containing 1